Navidea Biopharma files for Chapter 11 bankruptcy to pursue financial restructuring

[Chapter 11 Bankruptcy Paperwork]
FuzzMartin

Navidea Biopharmaceuticals (OTC:NAVBQ [https://seekingalpha.com/symbol/NAVBQ]) has announced [https://seekingalpha.com/pr/20259807-navidea-biopharmaceuticals-inc-files-for-bankruptcy] that it filed a voluntary petition for relief under Chapter 11, Subchapter V of the U.S. Bankruptcy Code.

The filing was made on October 1, 2025, in the U.S. Bankruptcy Court for the District of Delaware.

The company stated that Chapter 11 filing is intended to allow for an orderly restructuring of its financial obligations while maintaining limited operations to preserve value for its creditors and stakeholders.

Navidea plans to use the bankruptcy process to actively evaluate strategic alternatives, protect its core assets, and ensure equitable treatment for its creditors.

MORE ON NAVIDEA BIOPHARM

* Financial information for Navidea Biopharm [https://seekingalpha.com/symbol/NAVBQ/income-statement]